These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI. Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397 [Abstract] [Full Text] [Related]
3. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage. Hassan AE, Hassanzadeh B, Tohidi V, Kirmani JF. South Med J; 2010 May; 103(5):398-402. PubMed ID: 20375952 [Abstract] [Full Text] [Related]
4. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital]. Takahashi K, Iijima K, Oguro H, Bokura H, Nagai A, Yamaguchi S, Kobayashi S. No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212 [Abstract] [Full Text] [Related]
5. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO. J Stroke Cerebrovasc Dis; 2008 Aug; 17(3):121-8. PubMed ID: 18436152 [Abstract] [Full Text] [Related]
7. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores. Wendt M, Tütüncü S, Fiebach JB, Scheitz JF, Audebert HJ, Nolte CH. J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783 [Abstract] [Full Text] [Related]
8. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. J Neurol Sci; 2008 Apr 15; 267(1-2):57-61. PubMed ID: 17964602 [Abstract] [Full Text] [Related]
9. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D. Isr Med Assoc J; 2004 Feb 15; 6(2):70-4. PubMed ID: 14986460 [Abstract] [Full Text] [Related]
10. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. N Engl J Med; 1999 Jun 10; 340(23):1781-7. PubMed ID: 10362821 [Abstract] [Full Text] [Related]
12. IV t-PA therapy in acute stroke patients with atrial fibrillation. Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Yamashita S, Aoki J. J Neurol Sci; 2009 Jan 15; 276(1-2):6-8. PubMed ID: 19010485 [Abstract] [Full Text] [Related]
13. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. Ann Emerg Med; 2005 Sep 15; 46(3):243-52. PubMed ID: 16126134 [Abstract] [Full Text] [Related]
15. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study. Messé SR, Kasner SE, Cucchiara BL, Demchuk A, Tanne D, Ouyang B, Levine SR, NINDS t-PA Stroke Study Group. J Stroke Cerebrovasc Dis; 2011 Sep 15; 20(3):236-40. PubMed ID: 20656508 [Abstract] [Full Text] [Related]
20. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window. Li YH, Li MH, Zhao JG, Wang W. J Neuroimaging; 2011 Oct 15; 21(4):332-9. PubMed ID: 21121996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]